Status:

TERMINATED

Autoimmune Hepatitis Study

Lead Sponsor:

University of Rochester

Collaborating Sponsors:

National Institutes of Health (NIH)

Conditions:

Hepatitis, Autoimmune

Eligibility:

All Genders

18+ years

Brief Summary

The purpose of the study is to determine the role special antibodies play in possibly identifying Autoimmune Hepatitis through the following: Identify the response of specific T cells to antibodies a...

Detailed Description

The object of this protocol is to characterize and monitor auto antigen-specific T cell responses in blood and liver biopsies of patients with anti-SLA/LP or anti-LKM-positive autoimmune hepatitis. Th...

Eligibility Criteria

Inclusion

  • Male or female subjects,All ethnic groups, Over 18 years of age, anti-SLA/LP or anti-LKM-positive autoimmune hepatitis

Exclusion

  • Subjects with a hematocrit of \<25

Key Trial Info

Start Date :

January 1 2006

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

June 1 2008

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT00286663

Start Date

January 1 2006

End Date

June 1 2008

Last Update

July 9 2008

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.